116 related articles for article (PubMed ID: 38382691)
1. CENPA promotes glutamine metabolism and tumor progression by up-regulating SLC38A1 in endometrial cancer.
Li S; Zhang Z; Li Z; Yang L; Liu J; Liu Y; Liu Y; Hou Y; Mei M; Huang Y
Cell Signal; 2024 May; 117():111110. PubMed ID: 38382691
[TBL] [Abstract][Full Text] [Related]
2. CENPA functions as a transcriptional regulator to promote hepatocellular carcinoma progression via cooperating with YY1.
Liao J; Chen Z; Chang R; Yuan T; Li G; Zhu C; Wen J; Wei Y; Huang Z; Ding Z; Chu L; Liang J; Zhang B
Int J Biol Sci; 2023; 19(16):5218-5232. PubMed ID: 37928273
[TBL] [Abstract][Full Text] [Related]
3. Integrative analysis reveals that SLC38A1 promotes hepatocellular carcinoma development via PI3K/AKT/mTOR signaling via glutamine mediated energy metabolism.
Feng HG; Wu CX; Zhong GC; Gong JP; Miao CM; Xiong B
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15879-15898. PubMed ID: 37673823
[TBL] [Abstract][Full Text] [Related]
4. METTL3-mediated m
Liu HT; Zhao Y; Wang HC; Liu QL
Biochem Biophys Res Commun; 2024 Jul; 716():150039. PubMed ID: 38701556
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of SLC38A1 is associated with poorer prognosis in Chinese patients with gastric cancer.
Xie J; Li P; Gao HF; Qian JX; Yuan LY; Wang JJ
BMC Gastroenterol; 2014 Apr; 14():70. PubMed ID: 24712400
[TBL] [Abstract][Full Text] [Related]
6. The role of the histone H3 variant CENPA in prostate cancer.
Saha AK; Contreras-Galindo R; Niknafs YS; Iyer M; Qin T; Padmanabhan K; Siddiqui J; Palande M; Wang C; Qian B; Ward E; Tang T; Tomlins SA; Gitlin SD; Sartor MA; Omenn GS; Chinnaiyan AM; Markovitz DM
J Biol Chem; 2020 Jun; 295(25):8537-8549. PubMed ID: 32371391
[TBL] [Abstract][Full Text] [Related]
7. Hsa_circ_0003602 Contributes to the Progression of Colorectal Cancer by Mediating the miR-149-5p/SLC38A1 Axis.
Wu R; Tang S; Wang Q; Kong P; Liu F
Gut Liver; 2023 Mar; 17(2):267-279. PubMed ID: 36148577
[TBL] [Abstract][Full Text] [Related]
8. Glutamine and amino acid metabolism as a prognostic signature and therapeutic target in endometrial cancer.
Zhai L; Yang X; Cheng Y; Wang J
Cancer Med; 2023 Aug; 12(15):16337-16358. PubMed ID: 37387559
[TBL] [Abstract][Full Text] [Related]
9. CENPA knockdown restrains cell progression and tumor growth in breast cancer by reducing PLA2R1 promoter methylation and modulating PLA2R1/HHEX axis.
Wu G; Fan Z; Li X
Cell Mol Life Sci; 2024 Jan; 81(1):27. PubMed ID: 38212546
[TBL] [Abstract][Full Text] [Related]
10. CircRUNX1 functions as an oncogene in colorectal cancer by regulating circRUNX1/miR-485-5p/SLC38A1 axis.
Yu J; Chen X; Li J; Wang F
Eur J Clin Invest; 2021 Jul; 51(7):e13540. PubMed ID: 33769559
[TBL] [Abstract][Full Text] [Related]
11. High expression of SLC38A1 predicts poor prognosis in patients with de novo acute myeloid leukemia.
Li Y; Shao H; Da Z; Pan J; Fu B
J Cell Physiol; 2019 Nov; 234(11):20322-20328. PubMed ID: 31344987
[TBL] [Abstract][Full Text] [Related]
12. SLC38A1 promotes proliferation and migration of human colorectal cancer cells.
Zhou FF; Xie W; Chen SQ; Wang XK; Liu Q; Pan XK; Su F; Feng MH
J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):30-36. PubMed ID: 28224429
[TBL] [Abstract][Full Text] [Related]
13. Tripartite motif containing 33 demonstrated anticancer effect by degrading c‑Myc: Limitation of glutamine metabolism and proliferation in endometrial carcinoma cells.
Qi Y; Ma N; Zhang J
Int J Oncol; 2023 Dec; 63(6):. PubMed ID: 37859625
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA OGFRP1 regulates cell proliferation and ferroptosis by miR-299-3p/SLC38A1 axis in lung cancer.
Liu L; Su S; Ye D; Yu Z; Lu W; Li X
Anticancer Drugs; 2022 Oct; 33(9):826-839. PubMed ID: 36066402
[TBL] [Abstract][Full Text] [Related]
15. Long Noncoding RNA
Wang S; Du H; Sun P
Cancer Biother Radiopharm; 2021 Nov; 36(9):793-802. PubMed ID: 32700988
[No Abstract] [Full Text] [Related]
16. High Expression Levels of SLC38A1 Are Correlated with Poor Prognosis and Defective Immune Infiltration in Hepatocellular Carcinoma.
Liu Y; Yang Y; Jiang L; Xu H; Wei J
J Oncol; 2021; 2021():5680968. PubMed ID: 34697542
[TBL] [Abstract][Full Text] [Related]
17. Slc38a1 Conveys Astroglia-Derived Glutamine into GABAergic Interneurons for Neurotransmitter GABA Synthesis.
Qureshi T; Bjørkmo M; Nordengen K; Gundersen V; Utheim TP; Watne LO; Storm-Mathisen J; Hassel B; Chaudhry FA
Cells; 2020 Jul; 9(7):. PubMed ID: 32668809
[TBL] [Abstract][Full Text] [Related]
18. D-Serine Signaling and NMDAR-Mediated Synaptic Plasticity Are Regulated by System A-Type of Glutamine/D-Serine Dual Transporters.
Bodner O; Radzishevsky I; Foltyn VN; Touitou A; Valenta AC; Rangel IF; Panizzutti R; Kennedy RT; Billard JM; Wolosker H
J Neurosci; 2020 Aug; 40(34):6489-6502. PubMed ID: 32661027
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of Slc38a1 Gene Along with Promotion of Neurosphere Growth and Subsequent Neuronal Specification in Undifferentiated Neural Progenitor Cells Exposed to Theanine.
Takarada T; Ogura M; Nakamichi N; Kakuda T; Nakazato R; Kokubo H; Ikeno S; Nakamura S; Kutsukake T; Hinoi E; Yoneda Y
Neurochem Res; 2016 Feb; 41(1-2):5-15. PubMed ID: 25957749
[TBL] [Abstract][Full Text] [Related]
20. Recycling of SLC38A1 to the plasma membrane by DSCR3 promotes acquired temozolomide resistance in glioblastoma.
Lin R; Xu Y; Xie S; Zhang Y; Wang H; Yi GZ; Huang G; Ni B; Song H; Wang Z; Qi ST; Liu Y
J Neurooncol; 2022 Mar; 157(1):15-26. PubMed ID: 35187626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
